Literature DB >> 17027119

Effect of early decrease in the lesion size on late brain tissue loss, synaptophysin expression and functionality after a focal brain lesion in rats.

E Millerot-Serrurot1, A Chausset, C Mossiat, A Prigent-Tessier, N Bertrand, P Garnier, A Beley, C Marie.   

Abstract

The purpose of the present study is to determine the effects of early decrease in the lesion size on late brain tissue loss, synaptogenesis and functionality after a focal brain lesion in rats. The lesion was induced either to the cortex using the photothrombotic ischemic stroke or to the striatum using the malonate poisoning model. The cortical and striatal lesions amounted to 66-80 mm(3) at day 1 post-lesion and were reduced by 50% after the acute administration of dipyridyl (a liposoluble iron chelator) and aminoguanidine (an inhibitor of the inducible nitric oxide synthase), respectively. Loss of histologically intact tissue and synaptophysin expression as an indicator of synaptogenesis were examined at day 35 post-lesion. Both types of lesion resulted in synaptophysin upregulation in contralateral and ipsilateral cortical areas. On the contrary, brain tissue loss was greater after the striatal (-17%) than the cortical lesion (-5%). Synaptophysin expression and tissue loss were not different between drug- and vehicle-treated rats. Moreover, a set of standard neurological tests revealed a difference in deficit between the both types of lesion, yet only in the acute post-lesion stage. However, it did not distinguish between vehicle- and drug-treated rats whatever the lesion location. Our results indicate that late histological endpoints measurements are not recommended to probe the potential neuroprotective properties of a drug administered within the acute post-lesion stage. They also suggest that inhibition of cytotoxic mechanisms involved in lesion growth is of no clinical interest when it cannot lead to a long-term histological protection and/or increased synaptogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17027119     DOI: 10.1016/j.neuint.2006.08.016

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  6 in total

1.  Estradiol modulates post-ischemic cerebral vascular remodeling and improves long-term functional outcome in a rat model of stroke.

Authors:  Agnieszka A Ardelt; Randall S Carpenter; Merryl R Lobo; Huadong Zeng; Rajanikant B Solanki; An Zhang; Piotr Kulesza; Martin M Pike
Journal:  Brain Res       Date:  2012-04-21       Impact factor: 3.252

2.  Relevance of Post-Stroke Circulating BDNF Levels as a Prognostic Biomarker of Stroke Outcome. Impact of rt-PA Treatment.

Authors:  Marion Rodier; Aurore Quirié; Anne Prigent-Tessier; Yannick Béjot; Agnès Jacquin; Claude Mossiat; Christine Marie; Philippe Garnier
Journal:  PLoS One       Date:  2015-10-15       Impact factor: 3.240

3.  Long-Term Intranasal Nerve Growth Factor Treatment Favors Neuron Formation in de novo Brain Tissue.

Authors:  Nina Colitti; Franck Desmoulin; Alice Le Friec; Wafae Labriji; Lorenne Robert; Amandine Michaux; Fabrice Conchou; Carla Cirillo; Isabelle Loubinoux
Journal:  Front Cell Neurosci       Date:  2022-07-19       Impact factor: 6.147

4.  Quantitative assessment of stereotyped and challenged locomotion after lesion of the striatum: a 3D kinematic study in rats.

Authors:  Olivier Perrot; Davy Laroche; Thierry Pozzo; Christine Marie
Journal:  PLoS One       Date:  2009-10-27       Impact factor: 3.240

5.  Comparative effect of treadmill exercise on mature BDNF production in control versus stroke rats.

Authors:  Aurore Quirié; Marie Hervieu; Philippe Garnier; Céline Demougeot; Claude Mossiat; Nathalie Bertrand; Alain Martin; Christine Marie; Anne Prigent-Tessier
Journal:  PLoS One       Date:  2012-09-04       Impact factor: 3.240

6.  Microglial involvement in neuroplastic changes following focal brain ischemia in rats.

Authors:  Alexandre Madinier; Nathalie Bertrand; Claude Mossiat; Anne Prigent-Tessier; Alain Beley; Christine Marie; Philippe Garnier
Journal:  PLoS One       Date:  2009-12-01       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.